Who Owns Pulmonx Stock?
NASDAQ: LUNGHealthcareMedical DevicesUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 62.81%
- Held by insiders
- 4.64%
- Institutional holders
- 129
- Institutions 62.8%
- Insiders 4.6%
- Public and other 32.5%
Who owns Pulmonx stock?
Institutional investors own about 62.8% of Pulmonx's shares, spread across 129 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 4.64% of LUNG.
The largest institutional holders are Primecap Management Company (10.74%), Morgan Stanley (6.81%) and Soleus Capital Management, L.P. (6.49%). Together, the top 10 institutions control 40.6% of shares outstanding. In their latest filings, 3 of the top 10 institutions increased their LUNG positions and 5 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of LUNG
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Primecap Management Company | 4.61M | 10.74% | -2.4% |
| Morgan Stanley | 2.92M | 6.81% | -26.8% |
| Soleus Capital Management, L.P. | 2.79M | 6.49% | 0.0% |
| Vanguard Capital Management LLC | 1.63M | 3.80% | -0.3% |
| ExodusPoint Capital Management, LP | 1.22M | 2.85% | -37.0% |
| Almitas Capital LLC | 1.06M | 2.48% | +100.0% |
| Blackrock Inc. | 882.49K | 2.05% | -66.8% |
| Stonepine Capital Management, LLC | 815.44K | 1.90% | +6.1% |
| Jane Street Group, LLC | 758.23K | 1.77% | +468.9% |
| Braidwell LP | 752.54K | 1.75% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of LUNG
| Fund | Shares | % Held |
|---|---|---|
| PRIMECAP Odyssey Funds-PRIMECAP Odyssey Aggressive Growth Fund | 3.50M | 8.15% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.15M | 2.68% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 436.55K | 1.02% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 189.39K | 0.44% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 155.36K | 0.36% |
| iShares Trust-iShares Micro-Cap ETF | 136.24K | 0.32% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 73.77K | 0.17% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 62.01K | 0.14% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Growth Index Fund | 36.29K | 0.08% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 28.36K | 0.07% |
Frequently asked questions
Who is the largest shareholder of Pulmonx?
Primecap Management Company is the largest institutional shareholder of LUNG, owning 10.74% of shares outstanding (4.61M shares) as of its latest 13F filing.
What percentage of Pulmonx is owned by institutions?
Institutions own about 62.8% of LUNG shares and 65.9% of the public float.
How much of Pulmonx do insiders own?
Insiders, such as officers and directors, own about 4.64% of LUNG shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.